Calliditas Therapeutics Ab buy melinda
Start price
13.10.21
/
50%
€9.53
Target price
13.10.22
€11.50
Performance (%)
-21.25%
End price
14.10.22
€7.51
Summary
This prediction ended on 14.10.22 with a price of €7.51. The price of Calliditas Therapeutics Ab has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -21.25%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Calliditas Therapeutics Ab | - | - | - |
iShares Core DAX® | 1.056% | 1.056% | 18.108% |
iShares Nasdaq 100 | -1.886% | -0.160% | 26.970% |
iShares Nikkei 225® | 2.553% | 4.359% | 17.676% |
iShares S&P 500 | -0.434% | 0.224% | 24.986% |
According to melinda what are the pros and cons of Calliditas Therapeutics Ab for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Calliditas Therapeutics Ab diskutieren
Buy mit Kursziel 11,5
In the thread Trading Calliditas Therapeutics Ab
Die von melinda gewählte maximale Laufzeit wurde überschritten
Stopped prediction by melinda for Calliditas Therapeutics Ab
Calliditas Therapeutics Ab
Start price
Target price
Perf. (%)
€12.10
10.10.20
10.10.20
€14.00
04.11.21
04.11.21
-21.24%
13.10.21
13.10.21
Could be worthwhile Investment >10% per year